Font Size

SCREEN

Profile

Direction

Menu Style

In Brief
  1. ISIRV Journal: IRV Journal impact factor is now 4.4
  2. Abstract Submission is OPEN_OPTIONS XII 29 Sept-2 Oct 2024 Brisbane, Australia
  3. Register Now_5th International Symposium on Neglected Influenza Viruses | 8-10 April 2024 | Lexington USA
5th AVG International Symposium on Neglected Influenza Viruses

S. Mark Tompkins
Associate Professor, Department of Infectious Disease, University of Georgia

tompkins web

S. Mark Tompkins, Ph.D. is an Associate Professor of Infectious Diseases at the University of Georgia, Athens, Georgia, USA. He received his doctorate in Immunology from Emory University and then studied immune mechanisms of antigen- and virus-induced autoimmune diseases as a National Multiple Sclerosis Society Postdoctoral Fellow at Northwestern University Medical School. In 2002, Dr. Tompkins joined the Center for Biologics Evaluation and Research at the FDA (Bethesda, Maryland) as a Research Fellow, expanding his infectious diseases research, focusing on influenza virus vaccines and therapies. He was recruited to the University of Georgia in 2005 where he is a member of a NIAID Center of Excellence for Influenza Research and Surveillance. In 2012, Dr. Tompkins was awarded a Senior Fulbright Scholar’s Award to work with the Australian Animal Health Laboratories in Geelong, Australia for six months, where he worked on identification of novel antiviral drugs against Henipaviruses.

Dr. Tompkins’ research focuses on understanding the emergence, pathogenesis, prevention, and treatment of emerging infectious diseases with particular focus on zoonotic influenza viruses. These studies include surveillance for influenza virus in animal populations, susceptibility of different species to influenza infection, and influenza virus evolution. Areas of research include whole genome siRNA screening, miRNA screening and analysis and other analysis of non-coding RNA regulation of viral infections and disease. These studies focus on development of novel antiviral drugs and improved vaccines. Dr. Tompkins has particular interest in development of novel vaccines, therapeutic antibodies, and drugs for human and animal use and collaborates with academic and industrial institutions, nationally and internationally. The ultimate goal of his research is the development of novel diagnostics, vaccines, and therapies for infectious disease.

 
Photo courtesy of the University of Georgia, ©2012/photo by Andrew Davis Tucker.